Neonatal Seizures
Conditions
Keywords
Decision Support Algorithm, Neonatal Seizures, EEG
Brief summary
A Multicentre Clinical Evaluation of a Decision Support Algorithm for Neonatal Seizure Detection: ANSeR
Detailed description
This is a multi-centre study. It will be based on routine clinical practice but will also allow for the off-line retrospective application of ANSeR to a well-defined clinical population in order to establish the potential diagnostic utility of the algorithm.
Interventions
Software system for neonatal seizure detection recognition
Sponsors
Study design
Eligibility
Inclusion criteria
All term neonates at risk of seizures are eligible for the ANSeR study. Neonates ≥ 36 weeks gestation will be recruited if: They have a need for EEG monitoring.
Exclusion criteria
Consent of parents not obtained.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To quantify the overall diagnostic accuracy of the Algorithm. | up to 72 hours | To measure diagnostic accuracy of ANSeR (Algorithm) and clinicians (in routine clinical practice or optimised clinical practice) during the initial up to but not limited to 72 hour period of post-natal EEG monitoring, using an expert panel as the reference standard. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Inappropriate use/non-use of Anti Epileptic Drugs (AEDs) | up to 72 hours | To quantify the degree and duration of inappropriate use/non-use of AEDs with 1. the off-line application of the ANSeR algorithm and 2. routine clinical practice. To compare (a) and (b). |
| To examine factors that influence diagnostic accuracy in clinical practice. | up to 72 hours | To examine factors that influence diagnostic accuracy in clinical practice. |
Countries
Ireland, Netherlands, Sweden, United Kingdom